[Cytogenetical and clinico-hematological changes in myeloma disease].
D000328:Adult; D001773:Blood Cells; D001853:Bone Marrow; D001854:Bone Marrow Cells; D002869:Chromosome Aberrations; D025063:Chromosome Disorders; D005260:Female; D006801:Humans; D007621:Karyotyping; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D008696:Methandrostenolone / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood / Q000188:drug therapy / Q000473:pathology*; D010950:Plasma Cells; D011239:Prednisolone / Q000627:therapeutic use
D011239:Prednisolone; D008696:Methandrostenolone; D008558:Melphalan
Tsitogeneticheskie i kliniko-gematologicheskie izmeneniia pri mielomnoĭ bolezni.